Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation-Reference-Cited by-同舟云学术

Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation

Published:2011-06-30 Issue:3 Volume:54 Page:868-878
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sangro Bruno,Carpanese Livio,Cianni Roberto,Golfieri Rita,Gasparini Daniele,Ezziddin Samer,Paprottka Philipp M.,Fiore Francesco,Van Buskirk Mark,Ignacio Bilbao Jose,Maria Ettorre Giuseppe,Salvatori Rita,Giampalma Emanuela,Geatti Onelio,Wilhelm Kai,Thorsten Hoffmann Ralf,Izzo Francesco,Iñarrairaegui Mercedes,Ludovico Maini Carlo,Urigo Carlo,Cappelli Alberta,Vit Alessandro,Ahmadzadehfar Hojjat,Franz Jakobs Tobias,Lastoria Secondo,

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24451/fullpdf

Reference31 articles.

1. Risk factors for the rising rates of primary liver cancer in the United States;El-Serag;Arch Intern Med,2000

2. Design and endpoints of clinical trials in hepatocellular carcinoma;Llovet;J Natl Cancer Inst,2008

3. Current strategy for staging and treatment: the BCLC update and future prospects;Forner;Semin Liver Dis,2010

4. Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort;Marrero;HEPATOLOGY,2005

5. Prospective validation of the Barcelona Clinic Liver Cancer staging system;Cillo;J Hepatol,2006

Cited by 568 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy;Annals of Hepatology;2025-01

2. Mapping the landscape of Y90 radioembolisation research: a citation analysis of the top 100 papers;Egyptian Journal of Radiology and Nuclear Medicine;2024-08-28

3. The role of biomarkers and dosimetry parameters in overall and progression free survival prediction for patients treated with personalized 90Y glass microspheres SIRT: a preliminary machine learning study;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-09

4. Selective internal radiation therapy for unresectable HCC: The SIRT downstaging study;Hepatology Communications;2024-06-27

5. TACE combined Lenvatinib plus Camrelizumab versus TACE alone in efficacy and safety for unresectable hepatocellular carcinoma: a propensity score-matching study;BMC Cancer;2024-06-11